BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/5/2014 1:53:00 PM | Browse: 776 | Download: 855
Publication Name World Journal of Gastrointestinal Pathophysiology
Manuscript ID 8456
Country United Kingdom
Received
2013-12-28 15:02
Peer-Review Started
2013-12-28 19:43
To Make the First Decision
2014-01-15 16:26
Return for Revision
2014-01-20 13:54
Revised
2014-02-11 05:18
Second Decision
2014-04-09 16:33
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-09 16:40
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-05-19 07:56
Publish the Manuscript Online
2014-05-20 17:09
ISSN 2150-5330 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Topic Highlights
Article Title Low grade dysplasia in Barrett’s esophagus: Should we worry?
Manuscript Source Invited Manuscript
All Author List Vamshi P Jagadesham and Clive J Kelty
Funding Agency and Grant Number
Corresponding Author Clive J Kelty, PhD, FRCS, Department of Upper Gastrointestinal Surgery, Northern General Hospital, Herries Rd, Sheffield S5 7AU, United Kingdom. clive.kelty@sth.nhs.uk
Key Words Low grade dysplasia; Barrett’s esophagus; Endoluminal therapy; Radiofrequency ablation; Esophageal adenocarcinoma
Core Tip Low-grade dysplasia (LGD) in Barrett’s esophagus (BE) is an important entity and poses a significant risk of progression to esophageal adenocarcinoma. With the emergence of endoluminal therapy over the past decade there has been a paradigm shift in the management of LGD. Ablative therapy, such as radiofrequency ablation, has demonstrated promising results in the management of LGD with regards to safety, cost-effectiveness, durability and reduction in cancer risk. It is, however, critical that management should be through a shared-decision making process and “individualised”. It is our belief that physicians should “worry” about LGD in BE.
Publish Date 2014-05-20 17:09
Citation Jagadesham VP, Kelty CJ. Low grade dysplasia in Barrett’s esophagus: Should we worry? World J Gastrointest Pathophysiol 2014; 5(2): 91-99 Available from: URL: http://www.wjgnet.com/2150-5330/full/v5/i2/91.htm DOI: http://dx.doi.org/10.4291/wjgp.v5.i2.91
URL http://www.wjgnet.com/2150-5330/full/v5/i2/91.htm
DOI http://dx.doi.org/10.4291/wjgp.v5.i2.91
Full Article (PDF) WJGP-5-91.pdf
Full Article (Word) WJGP-5-91.doc
Manuscript File 8456-Review.doc
Answering Reviewers 8456-Answering reviewers.pdf
Copyright License Agreement 8456-Copyright assignment.pdf
Peer-review Report 8456-Peer reviews.pdf
Scientific Editor Work List 8456-Scientific editor work list.doc